CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-11-26 | BVF PARTNERS L P/IL 10% owner | Sale | −34,917 | $57.57 | $2.0M | 128,581 |
| 2013-11-25 | KOZARICH JOHN W Director | Exercise or conversion | +613 | $7.40 | $5K | 42,339 |
| 2013-11-25 | KOZARICH JOHN W Director | Exercise or conversion | +630 | $6.82 | $4K | 42,969 |
| 2013-11-25 | KOZARICH JOHN W Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −630 | 0 | ||
| 2013-11-25 | KOZARICH JOHN W Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −613 | 0 | ||
| 2013-11-20 | LAMATTINA JOHN L Director | Gift | −3,800 | 21,356 | ||
| 2013-11-18 | KOZARICH JOHN W Director | Exercise or conversion | +460 | $14.86 | $7K | 41,726 |
| 2013-11-18 | KOZARICH JOHN W Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −460 | 0 | ||
| 2013-11-18 | Sharp John P VP Finance and CFO | Exercise or conversion | +624 | $9.96 | $6K | 24,790 |
| 2013-11-18 | Sharp John P VP Finance and CFO | Sale | −1,123 | $53.00 | $60K | 23,667 |
| 2013-11-18 | Sharp John P VP Finance and CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −624 | 8,542 | ||
| 2013-10-22 | HIGGINS JOHN L President & CEO | Exercise or conversion | +5,850 | $21.00 | $123K | 112,431 |
| 2013-10-22 | HIGGINS JOHN L President & CEO | Exercise or conversion | +4,668 | $10.05 | $47K | 117,099 |
| 2013-10-22 | HIGGINS JOHN L President & CEO | Exercise or conversion · Incentive Stock Option (right to buy) | −4,668 | 15,675 | ||
| 2013-10-22 | HIGGINS JOHN L President & CEO | Exercise or conversion · Incentive Stock Option (right to buy) | −5,850 | 37,483 | ||
| 2013-10-18 | HIGGINS JOHN L President & CEO | Sale | −10,000 | $55.00 | $550K | 106,581 |
| 2013-09-23 | BVF PARTNERS L P/IL 10% owner | Sale | −211,217 | $44.50 | $9.4M | 530,410 |
| 2013-09-23 | BVF PARTNERS L P/IL 10% owner | Sale | −147,806 | $44.50 | $6.6M | 296,345 |
| 2013-09-12 | KNOTT DAVID M Director | Sale | −160,000 | $46.78 | $7.5M | 51,396 |
| 2013-08-30 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +9,499 | $21.00 | $199K | 27,427 |
Page 81 of 86 · 1,712 trades